Please try another search
(Reuters) - European stocks edged higher on Monday, with deal talks related to British consumer companies boosting the bluechip FTSE 100, while shares in Credit Suisse (SIX:CSGN) slipped after the Swiss bank's chairman quit following an internal probe into his personal conduct.
The pan-European STOXX 600 index rose 0.2% by 0806 GMT, with Asian markets choppy after China's central bank cut some key lending rates after mixed economic data, while a U.S. holiday made for thin trading. [MKTS/GLOB]
China-exposed miners and healthcare stocks were the top sectoral gainers in Europe, up about 0.8% each.
Lifting UK's FTSE 100, GlaxoSmithKline (NYSE:GSK) jumped 5.2% after it confirmed over the weekend that it had rejected Unilever (NYSE:UL)'s 50-billion-pound offer for its consumer healthcare business.
Unilever slid 5.2% after it signalled on Monday it would pursue the deal, calling it a "strong strategic fit".
Credit Suisse slipped 1.1% after Chairman Antonio Horta-Osorio quit following an internal probe into his personal conduct, including breaches of COVID-19 rules.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.